Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2095095900', 'doi': 'https://doi.org/10.1016/j.antiviral.2010.09.006', 'title': 'Novel Approaches to Vaginal Delivery and Safety of Microbicides: Biopharmaceuticals, Nanoparticles, and Vaccines', 'display_name': 'Novel Approaches to Vaginal Delivery and Safety of Microbicides: Biopharmaceuticals, Nanoparticles, and Vaccines', 'publication_year': 2010, 'publication_date': '2010-11-24', 'ids': {'openalex': 'https://openalex.org/W2095095900', 'doi': 'https://doi.org/10.1016/j.antiviral.2010.09.006', 'mag': '2095095900', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/21109069'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.antiviral.2010.09.006', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S137372404', 'display_name': 'Antiviral Research', 'issn_l': '0166-3542', 'issn': ['0166-3542', '1872-9096'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5025746769', 'display_name': 'Kevin J. Whaley', 'orcid': 'https://orcid.org/0000-0003-3856-6803'}, 'institutions': [{'id': 'https://openalex.org/I4210104471', 'display_name': 'Mapp Biopharmaceutical (United States)', 'ror': 'https://ror.org/01e47qp55', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210104471']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kevin J. Whaley', 'raw_affiliation_strings': ['Mapp Biopharmaceutical, Inc., San Diego, CA 92121, USA.'], 'affiliations': [{'raw_affiliation_string': 'Mapp Biopharmaceutical, Inc., San Diego, CA 92121, USA.', 'institution_ids': ['https://openalex.org/I4210104471']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041922458', 'display_name': 'Justin Hanes', 'orcid': 'https://orcid.org/0000-0001-9672-9821'}, 'institutions': [{'id': 'https://openalex.org/I145311948', 'display_name': 'Johns Hopkins University', 'ror': 'https://ror.org/00za53h95', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I145311948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Justin Hanes', 'raw_affiliation_strings': ['Department of Chemical and Biomolecular Engineering and Institute for NanoBiotechnology, Johns, Hopkins University, Baltimore, MD 21212, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Chemical and Biomolecular Engineering and Institute for NanoBiotechnology, Johns, Hopkins University, Baltimore, MD 21212, USA', 'institution_ids': ['https://openalex.org/I145311948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5086956796', 'display_name': 'Robin J. Shattock', 'orcid': 'https://orcid.org/0000-0002-4936-1718'}, 'institutions': [{'id': 'https://openalex.org/I165862685', 'display_name': "St George's, University of London", 'ror': 'https://ror.org/040f08y74', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I165862685', 'https://openalex.org/I4401726869']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Robin Shattock', 'raw_affiliation_strings': ["Center for Infection, Division of Cellular & Molecular Medicine, St. George's University of London, London SW1 ORE, UK"], 'affiliations': [{'raw_affiliation_string': "Center for Infection, Division of Cellular & Molecular Medicine, St. George's University of London, London SW1 ORE, UK", 'institution_ids': ['https://openalex.org/I165862685']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023574039', 'display_name': 'Richard A. Cone', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I145311948', 'display_name': 'Johns Hopkins University', 'ror': 'https://ror.org/00za53h95', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I145311948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richard A. Cone', 'raw_affiliation_strings': ['Mucosal Protection Laboratory, Department of Biophysics, Johns Hopkins University, Baltimore, 21218, USA'], 'affiliations': [{'raw_affiliation_string': 'Mucosal Protection Laboratory, Department of Biophysics, Johns Hopkins University, Baltimore, 21218, USA', 'institution_ids': ['https://openalex.org/I145311948']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5018390857', 'display_name': 'David R. Friend', 'orcid': 'https://orcid.org/0000-0002-8292-5466'}, 'institutions': [{'id': 'https://openalex.org/I156802259', 'display_name': 'Eastern Virginia Medical School', 'ror': 'https://ror.org/056hr4255', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I156802259']}, {'id': 'https://openalex.org/I2802034590', 'display_name': 'Contraception Research and Development', 'ror': 'https://ror.org/03mekzy91', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I2802034590']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David R. Friend', 'raw_affiliation_strings': ['CONRAD, Eastern Virginia Medical School, Arlington, VA, 22209, USA'], 'affiliations': [{'raw_affiliation_string': 'CONRAD, Eastern Virginia Medical School, Arlington, VA, 22209, USA', 'institution_ids': ['https://openalex.org/I156802259', 'https://openalex.org/I2802034590']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 5, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3730, 'currency': 'USD', 'value_usd': 3730, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 7.967, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 86, 'citation_normalized_percentile': {'value': 0.999676, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '88', 'issue': None, 'first_page': 'S55', 'last_page': 'S66'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10428', 'display_name': 'Vaginal Microbiome and Sexually Transmitted Infections', 'score': 0.9975, 'subfield': {'id': 'https://openalex.org/subfields/2404', 'display_name': 'Microbiology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10428', 'display_name': 'Vaginal Microbiome and Sexually Transmitted Infections', 'score': 0.9975, 'subfield': {'id': 'https://openalex.org/subfields/2404', 'display_name': 'Microbiology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12856', 'display_name': 'Production of Recombinant Pharmaceuticals in Plants', 'score': 0.9957, 'subfield': {'id': 'https://openalex.org/subfields/1305', 'display_name': 'Biotechnology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10920', 'display_name': 'Mucosal Drug Delivery Systems', 'score': 0.9954, 'subfield': {'id': 'https://openalex.org/subfields/3003', 'display_name': 'Pharmaceutical Science'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/vaginal-microbicide', 'display_name': 'Vaginal microbicide', 'score': 0.52955586}, {'id': 'https://openalex.org/keywords/drug-delivery', 'display_name': 'Drug Delivery', 'score': 0.502698}, {'id': 'https://openalex.org/keywords/sexual-transmission', 'display_name': 'Sexual transmission', 'score': 0.45202753}], 'concepts': [{'id': 'https://openalex.org/C197746943', 'wikidata': 'https://www.wikidata.org/wiki/Q68541106', 'display_name': 'Microbicide', 'level': 3, 'score': 0.9832885}, {'id': 'https://openalex.org/C117214928', 'wikidata': 'https://www.wikidata.org/wiki/Q7905570', 'display_name': 'Microbicides for sexually transmitted diseases', 'level': 4, 'score': 0.9599757}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5371732}, {'id': 'https://openalex.org/C97228660', 'wikidata': 'https://www.wikidata.org/wiki/Q7908502', 'display_name': 'Vaginal microbicide', 'level': 5, 'score': 0.52955586}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.47307333}, {'id': 'https://openalex.org/C3019340110', 'wikidata': 'https://www.wikidata.org/wiki/Q525512', 'display_name': 'Sexual transmission', 'level': 4, 'score': 0.45202753}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.340612}, {'id': 'https://openalex.org/C2908647359', 'wikidata': 'https://www.wikidata.org/wiki/Q2625603', 'display_name': 'Population', 'level': 2, 'score': 0.2129389}, {'id': 'https://openalex.org/C2986740045', 'wikidata': 'https://www.wikidata.org/wiki/Q31207', 'display_name': 'Health services', 'level': 3, 'score': 0.099128574}, {'id': 'https://openalex.org/C99454951', 'wikidata': 'https://www.wikidata.org/wiki/Q932068', 'display_name': 'Environmental health', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000890', 'descriptor_name': 'Anti-Infective Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D000890', 'descriptor_name': 'Anti-Infective Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000517', 'qualifier_name': 'prevention & control', 'is_major_topic': True}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D018258', 'descriptor_name': 'Herpesvirus 2, Human', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D053758', 'descriptor_name': 'Nanoparticles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D014621', 'descriptor_name': 'Vagina', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D014765', 'descriptor_name': 'Viral Vaccines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D014765', 'descriptor_name': 'Viral Vaccines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D000282', 'descriptor_name': 'Administration, Intravaginal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000890', 'descriptor_name': 'Anti-Infective Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000890', 'descriptor_name': 'Anti-Infective Agents', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D002626', 'descriptor_name': 'Chemistry, Pharmaceutical', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002626', 'descriptor_name': 'Chemistry, Pharmaceutical', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': False}, {'descriptor_ui': 'D002986', 'descriptor_name': 'Clinical Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003365', 'descriptor_name': 'Costs and Cost Analysis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004195', 'descriptor_name': 'Disease Models, Animal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004304', 'descriptor_name': 'Dosage Forms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004335', 'descriptor_name': 'Drug and Narcotic Control', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005079', 'descriptor_name': 'Excipients', 'qualifier_ui': 'Q000032', 'qualifier_name': 'analysis', 'is_major_topic': False}, {'descriptor_ui': 'D005079', 'descriptor_name': 'Excipients', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D005079', 'descriptor_name': 'Excipients', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000191', 'qualifier_name': 'economics', 'is_major_topic': False}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000635', 'qualifier_name': 'transmission', 'is_major_topic': False}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018258', 'descriptor_name': 'Herpesvirus 2, Human', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D014621', 'descriptor_name': 'Vagina', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014621', 'descriptor_name': 'Vagina', 'qualifier_ui': 'Q000821', 'qualifier_name': 'virology', 'is_major_topic': False}, {'descriptor_ui': 'D014765', 'descriptor_name': 'Viral Vaccines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014765', 'descriptor_name': 'Viral Vaccines', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.antiviral.2010.09.006', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S137372404', 'display_name': 'Antiviral Research', 'issn_l': '0166-3542', 'issn': ['0166-3542', '1872-9096'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/21109069', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.86}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 55, 'referenced_works': ['https://openalex.org/W1503489879', 'https://openalex.org/W1525927184', 'https://openalex.org/W1917235498', 'https://openalex.org/W1965087674', 'https://openalex.org/W1969789625', 'https://openalex.org/W1982211810', 'https://openalex.org/W1984488180', 'https://openalex.org/W1989407131', 'https://openalex.org/W1994294415', 'https://openalex.org/W1995896475', 'https://openalex.org/W1998013812', 'https://openalex.org/W2002061140', 'https://openalex.org/W2002574877', 'https://openalex.org/W2007300056', 'https://openalex.org/W2009473148', 'https://openalex.org/W2015694254', 'https://openalex.org/W2020266663', 'https://openalex.org/W2022905205', 'https://openalex.org/W2027373982', 'https://openalex.org/W2028313022', 'https://openalex.org/W2029561253', 'https://openalex.org/W2031911044', 'https://openalex.org/W2031962688', 'https://openalex.org/W2036717284', 'https://openalex.org/W2039062327', 'https://openalex.org/W2049620495', 'https://openalex.org/W2056238439', 'https://openalex.org/W2056568415', 'https://openalex.org/W2058043505', 'https://openalex.org/W2058408713', 'https://openalex.org/W2058632331', 'https://openalex.org/W2065072784', 'https://openalex.org/W2071026997', 'https://openalex.org/W2073791164', 'https://openalex.org/W2084162058', 'https://openalex.org/W2084600650', 'https://openalex.org/W2099308199', 'https://openalex.org/W2102002215', 'https://openalex.org/W2106853491', 'https://openalex.org/W2120000105', 'https://openalex.org/W2123686790', 'https://openalex.org/W2131304438', 'https://openalex.org/W2132622748', 'https://openalex.org/W2139642740', 'https://openalex.org/W2140294338', 'https://openalex.org/W2142998561', 'https://openalex.org/W2146087750', 'https://openalex.org/W2146432353', 'https://openalex.org/W2150953958', 'https://openalex.org/W2151393720', 'https://openalex.org/W2154513072', 'https://openalex.org/W2154855352', 'https://openalex.org/W2156761639', 'https://openalex.org/W2160780945', 'https://openalex.org/W2161358581'], 'related_works': ['https://openalex.org/W2803068055', 'https://openalex.org/W2626692807', 'https://openalex.org/W2186674490', 'https://openalex.org/W2160010002', 'https://openalex.org/W2067896431', 'https://openalex.org/W2022052587', 'https://openalex.org/W2001804657', 'https://openalex.org/W1996406226', 'https://openalex.org/W1986531110', 'https://openalex.org/W1211163381'], 'abstract_inverted_index': {'The': [0], 'HIV-1': [1, 169], 'epidemic': [2], 'remains': [3], 'unchecked': [4], 'despite': [5], 'existing': [6], 'technology;': [7], 'vaccines': [8, 134], 'and': [9, 27, 66, 75, 83, 113, 133, 143, 160, 198], 'microbicides': [10, 60, 95, 132], 'in': [11, 23, 192], 'development': [12, 58], 'may': [13, 39, 47, 106, 119, 163], 'help': [14], 'reverse': [15], 'the': [16, 121, 138, 187], 'epidemic.': [17], 'Reverse': [18], 'transcriptase': [19], 'inhibitors': [20], '(RTIs)': [21], 'formulated': [22, 79], 'gels': [24], 'tenofovir': [25], '(TFV)': [26], 'IVRs': [28, 84], '(dapivirine)': [29], 'are': [30], 'under': [31, 57], 'clinical': [32], 'development.': [33], 'While': [34], 'TFV': [35], 'or': [36], 'similar': [37], 'products': [38], 'prove': [40], 'successful': [41], 'for': [42, 85], 'HIV-1,': [43], 'alternatives': [44], 'to': [45, 93, 98], 'RTIs': [46], 'provide': [48], 'additional': [49], 'benefits,': [50], 'e.g.,': [51], 'broader': [52], 'STI': [53, 127], 'prevention.': [54], 'Biopharmaceutical': [55], 'agents': [56], 'as': [59], 'include': [61], 'cyanovirin,': [62], 'RANTES': [63], 'analogues,': [64], 'commensals,': [65], 'Mabs.': [67], 'Cost': [68], 'of': [69, 125, 131, 140, 156, 167, 175], 'manufacturing': [70], 'biopharmaceuticals': [71], 'has': [72, 135], 'been': [73], 'reduced': [74], 'they': [76], 'can': [77, 147], 'be': [78, 107, 120, 148], 'into': [80], 'tablets,': [81], 'films,': [82], 'vaginal': [86, 104], 'delivery.': [87, 101], 'Nanotechnology': [88], 'offers': [89], 'a': [90, 151, 176], 'novel': [91, 183], 'approach': [92], 'formulate': [94], 'potentially': [96], 'leading': [97], 'uniform': [99], 'epithelial': [100], 'Delivery': [102], 'through': [103], 'mucus': [105], 'possible': [108], 'by': [109], 'controlling': [110], 'nanoparticle': [111], 'size': [112], 'surface': [114], 'characteristics.': [115], 'Combining': [116], 'prevention': [117], 'modalities': [118], 'most': [122], 'effective': [123], 'means': [124], 'preventing': [126], 'transmission,': [128], 'importantly,': [129], 'codelivery': [130], 'demonstrated.': [136], 'Finally,': [137], 'safety': [139], 'microbicide': [141, 158, 184], 'preparations': [142], 'excipients': [144, 162], 'commonly': [145], 'used': [146], 'assessed': [149], 'using': [150], 'mouse/HSV-2': [152], 'susceptibility': [153], 'model.': [154], 'Screening': [155], 'new': [157], 'candidates': [159], 'formulation': [161], 'avoid': [164], 'past': [165], 'issues': [166], 'enhancing': [168], 'transmission.': [170], 'This': [171], 'article': [172], 'forms': [173], 'part': [174], 'special': [177], 'supplement': [178], 'covering': [179], 'several': [180], 'presentations': [181], 'on': [182, 189, 196], 'formulations': [185], 'from': [186], 'symposium': [188], '"Recent': [190], 'Trends': [191], 'Microbicide': [193], 'Formulations"': [194], 'held': [195], '25': [197], '26': [199], 'January': [200], '2010,': [201], 'Arlington,': [202], 'VA.': [203]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2095095900', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 3}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 6}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 6}, {'year': 2017, 'cited_by_count': 6}, {'year': 2016, 'cited_by_count': 5}, {'year': 2015, 'cited_by_count': 6}, {'year': 2014, 'cited_by_count': 11}, {'year': 2013, 'cited_by_count': 10}, {'year': 2012, 'cited_by_count': 10}], 'updated_date': '2024-09-17T16:11:38.485588', 'created_date': '2016-06-24'}